Omacor

Omacor

omega-3 triglycerides

Manufacturer:

Abbott

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Omega-3-acid ethyl esters 1,000 mg equiv to EPA (460) & DHA ethyl esters (380 mg)
Indications/Uses
Supplemental treatment in secondary prevention after MI in addition to other standard therapy. Endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient; type IV hypertriglyceridaemia in monotherapy; type IIb/III in combination w/ statins when control of triglycerides is insufficient.
Dosage/Direction for Use
Post MI 1 cap daily. Hypertriglyceridemia Initially 2 cap daily, may be increased to 4 cap daily.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to EPA, DHA, soya & peanut.
Special Precautions
Hypersensitivity to fish. Monitor patients on anticoagulant therapy. Monitor ALT & AST levels in patients w/ any sign of liver damage. Not for exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). Secondary endogenous hypertriglyceridemia (especially uncontrolled diabetes). Hepatic & renal impairment. Pregnancy & lactation. Childn. Elderly >70 yr.
Adverse Reactions
GI disorders including abdominal distension & pain, constipation, diarrhea, dyspepsia, flatulence, eructation, GERD, nausea or vomiting.
Drug Interactions
Increased bleeding time w/ aspirin & warfarin. NSAIDs & coumarin.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX06 - omega-3-triglycerides incl. other esters and acids ; Belongs to the class of other lipid modifying agents.
Presentation/Packing
Form
Omacor soft-gelatin cap 1000 mg
Packing/Price
28's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in